These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7817555)

  • 41. Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging.
    Bohdiewicz PJ
    J Nucl Med Technol; 1998 Sep; 26(3):155-63; quiz 170-1. PubMed ID: 9755434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
    Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
    Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal antibodies in ovarian tumor imaging.
    Fotiou S; Skarlos D; Tserkezoglou A; Aravantinos G; Malamitsi J; Koutoulidis K
    Eur J Gynaecol Oncol; 1988; 9(4):304-7. PubMed ID: 3391206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic significance of indium-111-capromab penetide.
    Sodee DB; Faulhaber PF; Nelson AD; Bakale G
    J Clin Oncol; 2004 Jan; 22(2):379-80; author reply 380-1. PubMed ID: 14722051
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.
    Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B
    Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.
    Granowska M; Mather SJ; Jobling T; Naeem M; Burchell J; Taylor-Papadimitriou J; Shepherd J; Britton KE
    Int J Biol Markers; 1990; 5(2):89-96. PubMed ID: 2283483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic imaging of gynecologic tumors with the monoclonal antibody 791T/36.
    Powell MC; Perkins AC; Pimm MV; Jetaily MA; Wastie ML; Durrant L; Baldwin RW; Symonds EM
    Am J Obstet Gynecol; 1987 Jul; 157(1):28-34. PubMed ID: 3605265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of B72.3 125-I monoclonal antibody in the radioimmunoguided surgery of colorectal neoplasms].
    Di Carlo V; Stella M; De Nardi P; Baratti D; Sassi I; Mangili F; Zito M; Badellino F; Dionigi R; Fazio F
    Ann Ital Chir; 1991; 62(3):245-9. PubMed ID: 1755605
    [No Abstract]   [Full Text] [Related]  

  • 50. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
    Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
    Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Technology for detecting cancer during surgery reaches phase III clinical trial.
    Oncology (Williston Park); 1991 May; 5(5):40. PubMed ID: 1832004
    [No Abstract]   [Full Text] [Related]  

  • 52. Radioimmunodetection in cancer identification.
    Goldenberg DM; Larson SM
    J Nucl Med; 1992 May; 33(5):803-14. PubMed ID: 1569493
    [No Abstract]   [Full Text] [Related]  

  • 53. The detection of ovarian cancer using 123J monoclonal antibody.
    Granowska M; Britton KE; Shepherd J
    Radiobiol Radiother (Berl); 1984; 25(1):153-60. PubMed ID: 6729079
    [No Abstract]   [Full Text] [Related]  

  • 54. PET scans improve management decisions, reduce unnecessary surgery in recurrent colorectal cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 May; 13(9):7-9. PubMed ID: 12484378
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations].
    Leitha T; Baur M; Steger G; Dudczak R
    Wien Klin Wochenschr; 1990 Sep; 102(17):503-9. PubMed ID: 2264338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18.
    Mardirossian G; Brill AB; Harwood SJ; Olsen J; Dwyer KA; Siegel JA
    J Nucl Med; 1998 Apr; 39(4):671-6. PubMed ID: 9544680
    [No Abstract]   [Full Text] [Related]  

  • 57. Radioimmunodetection of occult carcinoembryonic antigen-producing cancer.
    Haseman MK; Brown DW; Keeling CA; Reed NL
    J Nucl Med; 1992 Oct; 33(10):1750-6. PubMed ID: 1403140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings.
    Granowska M; Shepherd J; Britton KE; Ward B; Mather S; Taylor-Papadimitriou J; Epenetos AA; Carroll MJ; Nimmon CC; Hawkins LA
    Nucl Med Commun; 1984 Aug; 5(8):485-99. PubMed ID: 6533499
    [No Abstract]   [Full Text] [Related]  

  • 59. [Combined use of iodine 123 and technetium 99m pertechnetate in a recurring struma ovarii].
    Serafini A; Mejia J
    Rev Interam Radiol; 1978 Jan; 3(1):53-6. PubMed ID: 644187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
    Surwit EA
    Targeted Diagn Ther; 1992; 6():125-40. PubMed ID: 1576343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.